Literature DB >> 24607607

Colorimetric engineered immunoprobe for the detection and quantification of microcystins.

Larissa M Alvarenga1, Julien Muzard2, Aurélie Ledreux1, Cécile Bernard1, Philippe Billiald3.   

Abstract

Microcystins (MCs) are heptapeptide toxins produced by cyanobacteria. Their global occurrence in aquatic ecosystems has prompted the development of several detection methods, including antibody-based methods. Here, we propose to apply recombinant antibody technologies to the production of a bivalent colorimetric immunoprobe (scFv-AP) made of the so-called scFv fused to the alkaline phosphatase (AP) of Escherichia coli. Recombinant antibody technologies allow the development of specific probes with improved properties and suitable for the detection of MCs. The fusion protein was produced in the periplasm of recombinant bacteria and was used to develop a direct competitive enzyme immunoassay for specific detection of MCs without requiring further purification. The epitope recognized by the recombinant molecule was circumscribed to a motif common to all MCs. Such a genetic approach offers many advantages over chemical cross-linking of antibodies to colorimetric enzymes and may be adaptable to the analysis of water samples and in situ detection.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cyanotoxin; Detection; Immunotracer; Microcystin; Quantification; scFv

Mesh:

Substances:

Year:  2014        PMID: 24607607     DOI: 10.1016/j.jim.2014.02.014

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Generation and characterization of monoclonal antibody against Advanced Glycation End Products in chronic kidney disease.

Authors:  Alessandra Becker Finco; Ricardo Andrez Machado-de-Ávila; Rayana Maciel; Juliana De Moura; Philippe Billiald; Andrea Emilia Marques Stinghen; Larissa M Alvarenga
Journal:  Biochem Biophys Rep       Date:  2016-03-23

2.  Alpha-hemolysin nanopore allows discrimination of the microcystins variants.

Authors:  Janilson J S Júnior; Thereza A Soares; Laércio Pol-Fachin; Dijanah C Machado; Victor H Rusu; Juliana P Aguiar; Cláudio G Rodrigues
Journal:  RSC Adv       Date:  2019-05-10       Impact factor: 4.036

Review 3.  Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2015-09-02       Impact factor: 5.328

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.